Literature DB >> 32447550

Visual hallucinations and illusions in Parkinson's disease: the role of ocular pathology.

Ana Marques1, Steven Beze2, Bruno Pereira3, Carine Chassain4, Nathalie Monneyron2, Laure Delaby5, Celine Lambert2, Marie Fontaine6, Philippe Derost6, Bérengère Debilly6, Isabelle Rieu6, Simon J G Lewis7, Frédéric Chiambaretta2, Franck Durif6.   

Abstract

INTRODUCTION: Whether different mechanisms, particularly ocular pathology, could lead to the emergence of visual hallucinations (VH) (defined as false perceptions with no external stimulus) versus visual illusions (VI) (defined as a misperception of a real stimulus) in Parkinson's disease (PD) remains debated. We assessed retinal, clinical and structural brain characteristics depending on the presence of VH or VI in PD.
METHODS: In this case-control study, we compared retinal thickness using optical coherence tomography (OCT), between PD patients with: VI (PD-I; n = 26), VH (PD-H; n = 28), and without VI or VH (PD-C; n = 28), and assessed demographic data, disease severity, treatment, anatomical and functional visual complaints, cognitive and visuo-perceptive functions and MRI brain volumetry for each group of PD patients.
RESULTS: Parafoveal retina was thinner in PD-H compared to PD-C (p = 0.005) and PD-I (p = 0.009) but did not differ between PD-I and PD-C (p = 0.85). Multivariate analysis showed that 1/retinal parafoveal thinning and total brain gray matter atrophy were independently associated with the presence of VH compared to PD-I; 2/retinal parafoveal thickness, PD duration, sleep quality impairment and total brain gray matter volume were independent factors associated with the presence of VH compared to PD-C; 3/anterior ocular abnormalities were the only factor independently associated with the presence of illusions compared to PD-C.
CONCLUSION: These findings reinforce the hypothesis that there may be different mechanisms contributing to VH and VI in PD, suggesting that these two entities may also have a different prognosis rather than simply lying along a continuous spectrum. REGISTRATION NUMBER: Clinicaltrials.gov number NCT01114321.

Entities:  

Keywords:  Hallucinations; MRI; Neuro-ophthalmology; Parkinson’s disease; Retina

Mesh:

Year:  2020        PMID: 32447550     DOI: 10.1007/s00415-020-09925-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  4 in total

1.  Two-year longitudinal follow-up of visual illusions and hallucinations in Parkinson's disease.

Authors:  Steven Beze; Lucia Castellani; Bruno Pereira; Frédéric Chiambaretta; Franck Durif; Ana Marques
Journal:  J Neurol       Date:  2022-03-16       Impact factor: 6.682

2.  Visual illusions in Parkinson's disease: an interview survey of symptomatology.

Authors:  Chinami Sasaki; Kayoko Yokoi; Hiroto Takahashi; Tomoyuki Hatakeyama; Koji Obara; Chizu Wada; Kazumi Hirayama
Journal:  Psychogeriatrics       Date:  2021-10-06       Impact factor: 2.295

3.  Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia.

Authors:  Nicholas Murphy; Alison Killen; Rajnish Kumar Gupta; Sara Graziadio; Lynn Rochester; Michael Firbank; Mark R Baker; Charlotte Allan; Daniel Collerton; John-Paul Taylor; Prabitha Urwyler
Journal:  Front Neurol       Date:  2021-01-28       Impact factor: 4.003

4.  Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.

Authors:  Iris van der Lijn; Gera A de Haan; Famke Huizinga; Fleur E van der Feen; A Wijnand F Rutgers; Catherina Stellingwerf; Teus van Laar; Joost Heutink
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.